As hospital and health system CEOs work to advance key strategies in 2026 — from ambulatory investments to artificial intelligence integration — ...

Thank you, Ingrid, and good morning. At NovoCure, our mission is to extend survival in some of the most aggressive forms of cancer. Launching tumor treating field's therapy in non-small cell lung ...

The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than wh | CMS' ...

BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary ...

Fitch cited concerns that Humana’s EBITDA-based margins are unlikely to recover to levels supporting previous ratings. The downgrade reflects elevated healthcare utilization across the sector and ...

Mid-Atlantic Permanente Medical Group shows how trusted data and technology can turn value-based care into better outcomes, ...

Seeing a private specialist increasingly comes with massive gap payments. On average, out-of-pocket fees to see a specialist amount to about $300 a ...

Self-insured employers face legal challenges in adopting value-based models, including ERISA fiduciary duties, HIPAA restrictions, and antitrust concerns. Standardized data definitions and performance ...

The Centers for Medicare and Medicaid Services is proposing enhancements to the Medicare Advantage and Part D Star Ratings program. Beginning in the 2027 measurement year, CMS proposes to remove ...

The CMS is proposing to overhaul the Medicare Advantage star ratings system, including by culling a dozen quality measures and removing a health equity reward. In a proposed rule released Tuesday, the ...

Older adults with dementia who may benefit from antipsychotic medications are being harmed by the Centers for Medicare & Medicaid Services’ (CMS) Long-Stay Antipsychotic Medication quality measure.